Holders of a little-known security tied to Bank of America Corp.’s stock price may be rolling in the dough.
A series of securities known as Bank of America TARP B warrants, issued in the wake of the financial crisis in 2009 with a strike price of $30.79, are set to pay out after the stock surged past that point for the first time on Friday. Shares closed at $31.19, up from $30.66 a day earlier.
The warrants last traded at $2.86, the highest price in more than six years. They were issued at $2.55 and fell to a record low of less than 7 cents in 2016. Holders who bought around that low price have reaped returns of almost 4,000 percent on their investment.
Michigan’s state treasury is the largest holder, with more than 10 million warrants. Its first registered holding date is Sept. 30, 2014, when the price was 96 cents, and the average cost of its warrants is 79 cents. Billionaire hedge fund manager John Paulson is the next-biggest holder with almost 9 million warrants. Paulson & Co. registered its first holding in 2010, and bought the warrants at an average price of $2.53 each.
Top Low Price Stocks To Buy Right Now: The Middleby Corporation(MIDD)
- [By Motley Fool Staff]
A maker of commercial and industrial kitchen equipment may seem like an unusual company for Tom and David Gardner to fall in love with — no matter how how high-quality those ovens and food processors are — but Middleby(NASDAQ:MIDD) is a bit more than that. And the biggest reason why has a lot to do with its CEO, Selim Bassoul, who was brought in specifically to give the company a culture.
- [By Motley Fool Staff]
In this segment of the Motley Fool Money podcast, host Chris Hill asks Fool analysts Jason Moser, Andy Cross, and Ron Gross to tell us about the companies they have their eyes on this week and why: Titan International(NYSE:TWI), Middleby(NASDAQ:MIDD), and Idexx Laboratories(NASDAQ:IDXX).
- [By Dan Caplinger]
Wednesday was a strong day on Wall Street, and major benchmarks posted solid gains of around 1%. Market participants were generally happy about oil prices moving back into the $70s, hoping for a rebound in hard-hit areas of the country that had taken advantage of the triple-digit oil prices of the early 2010s by dramatically ramping up production of shale plays and similar opportunities. Yet even with the generally favorable mood, some stocks weren’t able to join the rally. Kinross Gold (NYSE:KGC), Weibo (NASDAQ:WB), and Middleby (NASDAQ:MIDD) were among the worst performers on the day. Here’s why they did so poorly.
- [By Ethan Ryder]
Middleby (NASDAQ: MIDD) and Tennant (NYSE:TNC) are both industrial products companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation and risk.
- [By Rich Smith]
History repeated itself. For the second earnings quarter in a row, shares of commercial oven-maker Middleby (NASDAQ:MIDD)are down 13.7% as of 11 a.m. EDT after the company reported Q1 sales and earnings that fell short of Wall Street estimates.
Top Low Price Stocks To Buy Right Now: Daily Journal Corp. (S.C.)(DJCO)
- [By Ethan Ryder]
BidaskClub downgraded shares of Daily Journal (NASDAQ:DJCO) from a buy rating to a hold rating in a research report released on Tuesday.
Separately, TheStreet raised shares of Daily Journal from a c- rating to a b rating in a report on Monday, February 12th.
Top Low Price Stocks To Buy Right Now: Great Western Bancorp, Inc.(GWB)
- [By Stephan Byrd]
Great Western Bancorp (NYSE: GWB) and Seacoast Banking Co. of Florida (NASDAQ:SBCF) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability.
Top Low Price Stocks To Buy Right Now: CytomX Therapeutics, Inc.(CTMX)
- [By Shane Hupp]
Shares of CytomX Therapeutics (NASDAQ:CTMX) have earned an average recommendation of “Buy” from the thirteen research firms that are currently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $39.86.
- [By Lisa Levin] Gainers
Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'.
CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting.
Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss.
Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session.
Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results.
World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading.
Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday.
Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday.
Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday.
Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.
- [By Logan Wallace]
Shares of CytomX Therapeutics (NASDAQ:CTMX) have received an average recommendation of “Buy” from the twelve research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $40.17.